Overview
Pendulum Therapeutics is a genuinely different proposition from most of this category. It was founded by PhD microbiome researchers, it is the only US brand offering live Akkermansia muciniphila, its capsules are delayed-release and third-party tested, and — unusually — it has actually run clinical trials and published data.
That last point deserves credit and precision in equal measure. Pendulum Glucose Control is described as the first and only clinically shown medical probiotic designed for the dietary management of type 2 diabetes, with data supporting lower A1C and reduced blood glucose spikes. Its patented formulation contains five strains of anaerobic bacteria including Clostridium butyricum. That is a real, narrow, defensible claim, and very few supplement companies have anything comparable.
The GLP-1 claim is a different matter. Pendulum’s own GLP-1 science page cites work showing that Akkermansia muciniphila secretes a GLP-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice (Yoon et al., Nature Microbiology, 2021), alongside a dose-dependent increase of GLP-1 by Clostridium butyricum in a cell model.
So the honest summary is this: the company is credible, one product has real human outcome data on a different endpoint, and the GLP-1 mechanism specifically is supported by mouse and cell studies. A Yahoo Health review notes that unlike Glucose Control, Metabolic Daily’s effectiveness has not been confirmed in a clinical trial. Pendulum is the best of this category — which is a comment on the category as much as on Pendulum.
What the Evidence Actually Shows
Actually Runs Clinical Trials
Pendulum Glucose Control has published human data supporting lower A1C and reduced glucose spikes for the dietary management of type 2 diabetes. In a category where ’clinically studied ingredients’ usually means someone else studied an ingredient, running and publishing your own product trial is a meaningful difference.
The Only US Live Akkermansia
Akkermansia muciniphila is an anaerobe that is genuinely difficult to manufacture as a live product. Pendulum is the only US brand offering it live, with delayed-release capsules at 100M AFU per capsule and third-party testing. That is a real technical achievement, independent of what it does for you.
It Publishes Its Citations — Including the Mouse Ones
Pendulum’s GLP-1 science page cites the Yoon 2021 Nature Microbiology paper directly, including that the work was in mice. Publishing your evidence base transparently, species and all, lets a reader evaluate it. Most competitors do not give you that option.
The Gap Between Mechanism and Outcome Is the Whole Story
A bacterium that secretes a GLP-1-inducing protein in mice is scientifically interesting. It does not establish that taking that bacterium as a capsule produces weight loss in humans. WellnessPulse’s assessment is that Akkermansia has shown gut benefits in animal studies but more trials are needed to know whether they apply to humans.
✓ Pros
- •Founded by PhD microbiome researchers – genuine scientific team
- •Published human trial data on A1C – for Glucose Control specifically
- •Only US brand with live Akkermansia muciniphila – a real manufacturing feat
- •Third-party tested – disclosed rather than assumed
- •Delayed-release capsules – appropriate for anaerobic strains
- •Publishes its citations openly – including the preclinical ones
- •Gut barrier claims are better supported – than the GLP-1 claims
- •100M AFU per capsule – potency stated clearly
✗ Cons
- •GLP-1 mechanism evidence is mouse and cell studies – not human outcomes
- •No human weight-loss outcome data – for the GLP-1 products
- •Expensive – among the priciest options in the category
- •Metabolic Daily not confirmed in a clinical trial – per Yahoo Health
- •A1C data does not transfer to weight claims – different endpoint, different product
- •Marketing outruns the evidence – third-party sellers make stronger claims than Pendulum’s own science page
- •Not FDA-reviewed – supplements are not assessed for efficacy before sale
If You Want an Actual GLP-1
Pendulum is the most credible company here, but its GLP-1 evidence is preclinical. If you want the outcomes GLP-1 medications produce, that requires the medications — now from around $99 a month all-in.
What Is In It
Regulatory Status
Dietary supplement, with one product positioned as a medical probiotic. Pendulum Glucose Control is described as a medical probiotic for the dietary management of type 2 diabetes — a specific regulatory category distinct from a drug. None of these products are FDA-approved medications. The FDA does not review dietary supplements for safety or effectiveness before sale.
Pendulum Akkermansia
Subscription pricing — confirm current rate directly100M AFU live Akkermansia muciniphila per capsule with prebiotic chicory inulin fibre, delayed release, third-party tested, 30 capsules. Pendulum describes it as clinically shown to fortify the gut lining and reduce gut permeability — a gut claim, not a weight claim.
Pendulum GLP-1 Probiotic
Subscription pricing — confirm current rate directlyCombines Akkermansia muciniphila with Clostridium butyricum. Marketed around supporting the body’s own GLP-1 production. The supporting citations on Pendulum’s science page are a mouse study and a cell model.
Pendulum Glucose Control
Subscription pricing — confirm current rate directlyThe product with genuine human outcome data. A patented formulation of five anaerobic strains including Clostridium butyricum, described as the first clinically shown medical probiotic for the dietary management of type 2 diabetes, supporting lower A1C and reduced glucose spikes.
Pendulum GLP-1 Probiotic Pro
Subscription pricing — confirm current rate directlyA higher-tier formulation featuring Akkermansia muciniphila and Clostridium butyricum, sold partly through practitioner channels.
Polyphenol Boosters
Sold separatelyMarketed as prebiotic support to improve Akkermansia performance. An additional cost on top of the base subscription.
Be precise about which product carries which evidence. Glucose Control has published human A1C data. The GLP-1 Probiotic and Akkermansia products carry gut-barrier claims and a GLP-1 mechanism supported by preclinical work. Third-party retailers frequently blur these distinctions in ways Pendulum’s own science page does not.
Pricing and Subscription Terms
| Cost Item | What You Pay |
|---|---|
| Pricing model | Subscription-based with subscribe-and-save discounts; confirm current rates directly |
| Position in category | Among the most expensive GLP-1 supplement options |
| Polyphenol Boosters | Sold separately, adding to the total cost |
| Prescription required | No |
| FDA review before sale | No — dietary supplements are not FDA-reviewed for safety or effectiveness |
| Third-party testing | Yes — disclosed by the brand |
| Insurance | Not covered |
| HSA / FSA | Confirm with your plan administrator |
Pendulum sits at the premium end of this category, and a full regimen with Polyphenol Boosters costs more again. Worth noting for perspective: a premium probiotic subscription can approach the cost of prescription GLP-1 therapy at providers charging around $99 a month all-in — while carrying preclinical rather than human outcome evidence for its central claim.
How It Is Claimed to Work
The proposed mechanism
Akkermansia muciniphila reinforces the mucin layer of the gut lining and, per preclinical work, secretes a protein that induces GLP-1. Clostridium butyricum produces butyrate, which is proposed to stimulate GLP-1 release.
What the mouse study showed
Yoon et al. (Nature Microbiology, 2021) found that Akkermansia muciniphila secretes a GLP-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. This is Pendulum’s own cited source, and it is a mouse study.
What the cell model showed
A dose-dependent increase of GLP-1 by Clostridium butyricum in a cell model. Again scientifically reasonable, and again not a human outcome.
What has been shown in humans
Glucose Control has published human data supporting lower A1C and reduced glucose spikes for the dietary management of type 2 diabetes. That is a real result — on a different endpoint, for a different product, than weight loss via GLP-1.
The gut-barrier claim is separate and better supported
Pendulum describes Akkermansia as clinically shown to fortify the gut lining and reduce gut permeability. If gut health is what you want, that claim stands on firmer ground than the GLP-1 framing does.
Set expectations accordingly
If you take this expecting gut and possibly glycaemic benefit, you are aligned with the evidence. If you take it expecting GLP-1-medication-like weight loss, you are relying on an extrapolation from mice that has not been demonstrated in people.
Product Details at a Glance
| Detail | Pendulum GLP-1 Probiotic |
|---|---|
| Product type | Dietary supplement — live probiotic capsules; one product positioned as a medical probiotic |
| Key ingredients | Akkermansia muciniphila (100M AFU), Clostridium butyricum, Bifidobacterium strains, chicory inulin prebiotic fibre |
| Format and serving | Delayed-release capsules, typically 30 per bottle, taken daily |
| Claimed mechanism | Akkermansia reinforces the gut mucin layer; preclinical work suggests it secretes a GLP-1-inducing protein. Clostridium butyricum produces butyrate, proposed to stimulate GLP-1 release. |
| Evidence in humans | Limited for GLP-1 claims; genuine for A1C. Glucose Control has published human data supporting lower A1C and reduced glucose spikes. The GLP-1 mechanism itself is cited from a mouse study (Yoon et al., Nature Microbiology 2021) and a cell model. Yahoo Health notes Metabolic Daily’s effectiveness has not been confirmed in a clinical trial. |
| Third-party testing | Third-party tested — disclosed by the brand, which is not standard in this category |
| Regulatory status | Dietary supplement under DSHEA; Glucose Control positioned as a medical probiotic for dietary management of type 2 diabetes. Not FDA-approved medications. |
| Prescription required | No |
| Price | Premium end of the category; subscription-based. Confirm current rates directly. |
| Subscription | Subscribe-and-save model; Polyphenol Boosters sold separately |
| Cancellation policy | Confirm subscription cancellation terms directly with Pendulum before enrolling |
| Refund policy | Confirm the refund policy directly with Pendulum |
| Safety and interactions | Probiotics are generally well tolerated. People who are immunocompromised, critically ill or have central venous catheters should consult a clinician before taking live probiotics. Check with your clinician before combining with prescription medication. |
| HSA / FSA | Confirm with your plan administrator |
| Where to buy | Direct from Pendulum, plus pharmacy and practitioner channels |
Who Might Reasonably Consider It
✓ Best For:
- • People whose primary interest is gut barrier and microbiome health
- • Patients managing type 2 diabetes who want the Glucose Control product specifically, alongside clinical care
- • Anyone who values third-party testing and published citations
- • People who want the most scientifically credible option in this category
- • Those comfortable paying a premium for manufacturing quality
- • Anyone who understands they are buying a mechanism hypothesis, not an outcome
✗ Not Best For:
- • People expecting weight loss comparable to GLP-1 medications
- • Anyone who wants human outcome evidence for the GLP-1 claim specifically
- • Cost-sensitive buyers — this is the premium end of the category
- • People who are immunocompromised without clinician guidance
- • Anyone treating this as a substitute for diabetes or obesity medication
Limitations and What It Will Not Do
- ⚠️The GLP-1 mechanism rests on preclinical evidence. Pendulum’s own science page cites a mouse study and a cell model — scientifically legitimate sources, but not human outcome data.
- ⚠️The genuine human trial data is for Glucose Control on A1C and glucose spikes, which is a different product and a different endpoint from weight loss via GLP-1.
- ⚠️Yahoo Health notes that unlike Glucose Control, Metabolic Daily’s effectiveness has not been confirmed in a clinical trial.
- ⚠️WellnessPulse’s assessment is that Akkermansia has shown gut benefits in animal studies but more trials are needed to determine whether they apply to humans.
- ⚠️Third-party retailers make considerably stronger GLP-1 claims than Pendulum’s own science page does. Read the manufacturer’s citations rather than a reseller’s summary.
- ⚠️Pricing sits at the premium end, and a full regimen with Polyphenol Boosters can approach the monthly cost of prescription GLP-1 therapy at the cheapest providers.
Alternatives to Pendulum GLP-1 Probiotic
Akkermansia Probiotics
The wider ingredient category, including cheaper competitors.
Nature Made GLP-1 Nutritional Support
Nutrient support without hormone claims, at a fraction of the cost.
Do GLP-1 Supplements Work?
The full evidence picture across this category.
Coreage RX
Prescription GLP-1 therapy at a flat $99/month with clinical oversight.
Frequently Asked Questions
Does Pendulum’s GLP-1 Probiotic actually raise GLP-1?
Pendulum’s own science page cites evidence that Akkermansia muciniphila secretes a GLP-1-inducing protein in mice, and that Clostridium butyricum produced a dose-dependent GLP-1 increase in a cell model. Those are preclinical findings. Human outcome data for the GLP-1 claim is not established.
Is Pendulum a legitimate company?
Yes, and it is the most scientifically credible operator in this category. It was founded by PhD microbiome researchers, third-party tests its products, publishes its citations transparently, and has run and published human clinical work on Glucose Control. Our reservations are about what the evidence supports, not about the company’s seriousness.
What does the Glucose Control clinical data show?
Pendulum Glucose Control is described as the first clinically shown medical probiotic for the dietary management of type 2 diabetes, with data supporting lower A1C and reduced blood glucose spikes. That is genuine human outcome data — on glycaemic endpoints, not on weight loss.
Why does Akkermansia matter?
It is a keystone gut bacterium that interacts with the gut lining and promotes mucin production, helping maintain the intestinal barrier. Pendulum is the only US brand offering it live, which is technically difficult since it is an anaerobe. The gut-barrier claims are better supported than the GLP-1 claims.
Is it worth the price?
If you want gut and microbiome support from the most credible manufacturer in the space, there is a case for it. If you are buying it for weight loss, the cost is hard to justify against evidence that currently comes from mice — particularly since prescription GLP-1 therapy starts around $99 a month at some providers.
Can I take it with a GLP-1 medication?
Probiotics are generally well tolerated, but check with your prescriber first. GoodRx advises talking to your prescriber before adding any supplement alongside a GLP-1-related medication.
Who should avoid live probiotics?
People who are immunocompromised, critically ill, or have central venous catheters should consult a clinician before taking live probiotic products. This is a general precaution for live-strain supplements rather than a Pendulum-specific issue.
Which Pendulum product should I look at?
It depends on your goal, and the products are not interchangeable. Glucose Control is the one with published human A1C data. Akkermansia is the gut-barrier product. The GLP-1 Probiotic is the one whose central claim rests on preclinical work. Match the product to the evidence you actually want.
The Bottom Line
Pendulum earns 3.5 out of 5 as a product and a Limited evidence rating — the highest product score in our booster category, and a fair illustration of why the two ratings need to be separate.
On product quality this is the class of the field. PhD microbiome founders, the only live Akkermansia in the US, delayed-release capsules, third-party testing, published citations, and genuine human trial data showing lower A1C for Glucose Control. Very little else in this category comes close on any of those measures, let alone all of them.
On the GLP-1 claim specifically, the evidence is preclinical. Pendulum’s own science page cites a mouse study — Yoon et al. in Nature Microbiology — and a cell model. That is honest sourcing, and it is also not human outcome data. The A1C result is real but it is a different endpoint on a different product, and third-party sellers routinely blur that distinction in ways Pendulum’s own materials do not.
Our recommendation: Buy Pendulum for gut and microbiome support, or for glycaemic support alongside clinical care, and you are broadly aligned with what the evidence shows. Buy it expecting GLP-1-medication-like weight loss and you are extrapolating from mice. Given that a full premium regimen can approach the cost of prescription GLP-1 therapy at around $99 a month, that is worth thinking about carefully. See our evidence guide for the wider picture.
Disclosure:
This review is based on publicly available information from Pendulum’s own website and GLP-1 science page, third-party retailer listings, and independent coverage including Yahoo Health and WellnessPulse, current as of August 25, 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews; we do not have a compensation relationship with Pendulum. Study citations described here are as published by Pendulum, including the Yoon et al. 2021 Nature Microbiology mouse study and a Clostridium butyricum cell model. Clinical data cited for Glucose Control relates to A1C and glucose management, not weight loss. Dietary supplements are not reviewed by the FDA for safety or effectiveness before sale. Pricing is subscription-based and varies — confirm current rates directly. This is not medical advice. We do not sell or ship supplements or medication.
⚕️ Medical Disclaimer:
This review is for informational purposes only and is not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or other concerning symptoms, seek medical care immediately. See our full medical disclaimer.
Or check out our top-rated provider